ArticleBlood advances2020
Goldmann L, Duan R, Kragh T, et al. Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT? Blood Adv. 2019;3(23):4021-4033.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.